SYPHILIS (Last Revision: May )
|
|
- Gordon Matthews
- 7 years ago
- Views:
Transcription
1 SYPHILIS (Last Revision: May ) Discuss all cases of suspected or proven syphilis with the attending physician prior to treatment, regardless of the stage or duration of infection. A. Diagnosis A serologic test for syphilis (STS) should be performed on all patients who have not been tested within the preceding 3 months and on any patient with undiagnosed genital lesions, regardless of time since the previous serology. Obtain a stat RPR for all patients with genital or perianal ulcerations that are not typical of genital herpes, warts that are not typical for condylomata acuminata, any undiagnosed general skin rash, or a patient who is a sexual contact of a partner with syphilis. It may be necessary in some cases to dilute the serum 1:8 to detect a positive RPR (prozone phenomenon). Perform a darkfield (DF) examination of any genital, anal, or perianal ulcerative lesion not typical of genital herpes. Staging is as follows: 1. Primary: Dark Field positive material from a chancre-like lesion, with positive serology (RPR+/FTA+ or RPR-/FTA+) and no past history of syphilis. In principal, primary syphilis should not be diagnosed without a positive darkfield microscopy. 2. Secondary: signs of systemic infection (bilaterally symmetric macular/ papular/papulosquamous/pustular skin lesions, alopecia, loss of eyelashes and lateral eyebrows, condylomata lata, mucous patches, generalized lymphadenopathy, fever and malaise) with positive serology (RPR+/FTA+). 3. Early latent: patient without symptoms/signs of syphilis with positive serology (RPR+/FTA+) known to have had in the past year: a) negative STS, b) symptoms of primary or secondary syphilis, c) exposure to known case of early (primary, secondary, or early latent) syphilis, or d) > 4-fold increase in titer on serial RPR. 4. Late latent: patient without symptoms/signs of syphilis with positive serology (RPR+/FTA+) and no prior treatment for syphilis who does not meet definition of early latent disease. 5. Establishing a diagnosis of syphilis in a patient with a prior history of treated syphilis requires a positive DF exam or > 4-fold rise in RPR titer. 6. Persistent infection is suggested by persistent/recurrent signs or symptoms of syphilis, a > 4-fold increase in RPR titer, or the failure of a high-titer RPR (> 1:32) to decrease > 4-fold within 12 months. 7. In ALL stages of syphilis, patients should be interviewed about possible neurologic symptoms (headache, photophobia, dizziness, memory loss,
2 weakness or numbness of arms or legs, seizures, difficulty concentrating, problems with vision or hearing). Those with any suggestion of neurologic problems should have a neurologic exam by the attending physician. A CSF exam should be considered, in consultation with the clinic physician, if any of the following are present: a) Neurologic or ophthalmologic signs or symptoms b) Documented treatment failure (recurrent symptoms or 4-fold-rise in absence of likely re-infection) c) Other evidence of active syphilis (aortitis, gumma, iritis) d) HIV infection 8. All patients with active syphilis should be advised to have an HIV test and a follow-up HIV test in 3 months. B. Treatment For all stages of syphilis, IM penicillin G is the treatment of choice, and is the only therapy with documented efficacy for neurosyphilis or syphilis in pregnancy. If doxycycline or erythromycin are given, it is extremely important to counsel the patient firmly about adherence to the regimen, since missing only a few doses will significantly increase the failure rate. 1. Early syphilis (primary, secondary, and early latent syphilis) a) Long-acting benzathine penicillin G (LAB) 2.4 million units IM b) Doxycycline 100 mg BID PO for 14 days; use only if patient is allergic to penicillin. Note 1: All penicillin injections should be given in a divided dose, half of the recommended dose to the upper outer quadrant of each hip. The patient should be asked to wait minutes, before leaving the clinic, in case of allergic response to the medication. Note 2: The Jarisch-Herxheimer reaction is an acute febrile reaction frequently accompanied by headache and myalgia, and other symptoms that usually occurs within the first 24 hours following treatment for early syphilis. Patients should be informed about this possible adverse reaction. Note 3: The use of alternative treatments, including azithromycin and ceftriaxone may be considered in certain cases, but should be discussed with the attending physician. 2. Late latent syphilis a) LAB 2.4 million units IM weekly for 3 doses (total 7.2 million units) b) Doxycycline 100 mg PO BID x 28 days; use only if patient is allergic to penicillin.
3 Note: If a patient misses a dose of penicillin in the course of weekly therapy for late syphilis, the sequence of injections must be restarted. 3. Neurosyphilis, both symptomatic and asymptomatic Patient with neurosyphilis need to be managed in combination with the AIDS/ID clinic or inpatient medicine service. There are no satisfactory alternatives to penicillin for treatment of neurosyphilis and those with a history of penicillin allergy should be skin-tested and, if necessary, desensitized. a) The treatment of choice is hospitalization for penicillin G, million units IV daily for 14 days, followed by weekly injections of LAB 2.4 million units for 3 weeks. b) Procaine penicillin G 2.4 million units IM daily plus probenecid 500 mg PO qid, both for days, followed by weekly injections of LAB 2.4 million units for 21 days. 4. Syphilis in pregnancy: Penicillin is the only treatment known to be effective in preventing or treating syphilis in the fetus. In case of penicillin allergy, refer for penicillin desensitization and treatment. Treatment of early syphilis in women in the second half of pregnancy should be undertaken with obstetrical consultation as the Jarisch-Herxheimer reaction may lead to premature labor and fetal distress. C. Follow-up Treatment failure is common in all stages of syphilis, even with recommended treatment regimens. In addition to resolution of signs and symptoms, the serological response is used to define cure. Most patients should be seen on the following schedules (although visits may be individualized by the clinic physician): 1. Early syphilis (primary, secondary, early latent): a. Clinic examination after 1 week. b. Repeat serology (quantitative RPR) 6 and 12 months after treatment. 2. Late syphilis: a. Repeat serology (quantitative RPR) 6, 12 and 24 months after treatment. b. Evaluate for neurosyphilis if the RPR titer increases 4-fold, an initially high titer ( 1:32) fails to fall 4-fold in months, or if signs or symptoms of syphilis develop. 3. Neurosyphilis:
4 a. Repeat serology (quantitative RPR) at 6, 12 and 24 months after treatment b. Follow-up CSF examination at 6-month intervals until cell count is normal. D. Management of contacts Refer all patients with syphilis to CDPHE DIS staff for partner notification interview. 1. To determine risk of partners, the time periods before treatment are a) 3 months plus duration of symptoms for primary syphilis; b) 6 months plus duration of symptoms for secondary syphilis; and c) 1 year for early syphilis 2. Contacts of patients with primary, secondary, or early latent syphilis: Routine history, examination, and syphilis serology, including stat RPR; administer epidemiologic treatment for all contacts within the preceding 3 months, regardless of syphilis serology (LAB 2.4 million units IM x 1). Treponomal test (FTA) should be performed for all contacts to syphilis, since they may be positive when non-treponomal tests (RPR, VDRL) are still negative in early syphilis. 3. Contacts of patients with late syphilis: serology (RPR, FTA) in all longterm contacts, and for the children of infected women; treat only if positive. 4. Contacts of patient with latent syphilis of unknown duration (no prior serologic test) should be managed as are contacts of early latent syphilis even though the source contact patient is typically treated for possible late latent infection. 5. For purposes of partner notification and presumptive treatment of exposed sex partners, patients with syphilis of unknown duration who have high treponemal serologic tests (i.e., >1:32) can be assumed to have early syphilis. However, serologic tests should not be used to differentiate early from latent syphilis for the purpose of treatment. 6. Advise sexual abstinence for 1 week after one-time penicillin for early syphilis therapy or until completion of treatment with other regimens. E. Syphilis in HIV-Infected Patients 1. Clinic physician should see all HIV-positive syphilis patients to assess the presence of neurologic problems. 2. Patients with primary, secondary, and confirmed early latent syphilis should be treated with LAB 2.4 million units once, as for HIV-negative patients. Those with late latent syphilis, or syphilis of unknown duration, should have a CSF exam prior to treatment, especially if neurologic symptoms or signs, treatment failure, or low CD4 count (<200) are
5 present. If the patient has a normal CSF exam then he/she should be treated with LAB 2.4 mu weekly x 3; if the patient has CSF consistent with neurosyphilis then he/she should be managed the same as patients with neurosyphilis. Depending on the patient s circumstances, the attending physician has the discretion to authorize starting treatment prior to CSF exam. 3. Penicillin regimens should be used whenever possible for all stages of syphilis in HIV-infected patients. Penicillin-allergic patients should be skin-tested and, if positive, considered for desensitization. The efficacy of alternative non-penicillin regimens in HIV-infected persons has not been studied. 4. In order to detect early treatment failure, it is important that HIV-infected patients with early syphilis have follow-up serology performed at 3, 6, 9, 12, and 24 months, while those with late latent syphilis should have follow-up serology performed at 6, 12, 18, and 24 months after therapy. Patients with late latent syphilis who develop symptoms consistent with syphilis, a 4-fold increase in RPR titer, or whose RPR fails to decline 4-fold should have a repeat CSF examination and re-treatment for late latent syphilis. Patients with early syphilis whose titers increase or fail to decrease 4-fold within 6 months should undergo a CSF exam and be retreated as for late latent syphilis.
California Guidelines for STD Screening and Treatment in Pregnancy
California Guidelines for STD Screening and Treatment in Pregnancy These guidelines were developed by the California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch
More informationTreatment of sexually transmitted and other genital infections
www.bpac.org.nz keyword: sti Treatment of sexually transmitted and other genital infections Key reviewer: Dr Murray Reid, Sexual Health Physician, Auckland Sexual Health Service General points: If one
More informationFrequently Asked Questions
Guidelines for Testing and Treatment of Gonorrhea in Ontario, 2013 Frequently Asked Questions Table of Contents Background... 1 Treatment Recommendations... 2 Treatment of Contacts... 4 Administration
More informationTREATMENT OF STI CONTACTS
This decision support tool is effective as of October 2014. For more information or to provide feedback on this or any other decision support tool, email certifiedpractice@crnbc.ca TREATMENT OF STI CONTACTS
More informationSexually Transmitted Infections (STI) One Day Update
Sexually Transmitted Infections (STI) One Day Update February 2015 Overview STI Guideline Changes National STI Services Results Reporting High Transmission Areas: Key Populations STI Guideline Changes
More informationRhode Island Department of Health Division of Infectious Diseases and Epidemiology
Rhode Island Department of Health Division of Infectious Diseases and Epidemiology STD (Sexually Transmitted Disease) PROGRAM Expedited Partner Therapy (EPT) for STDs Guidance for Medical Providers in
More information2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential. STD Treatment Guidelines. How are the guidelines prepared?
2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential Bradley Stoner, MD, PhD Associate Professor, Washington University School of Medicine Medical Director, St. Louis STD/HIV
More informationSyphilis: Aid to Diagnosis
STD, HIV, AND TB SECTION Syphilis: Aid to Diagnosis This document contains extremely graphic images. These images are intended to help health care professionals identify and diagnose syphilis. All images
More informationFrequently Asked Questions
Frequently Asked Questions Testing for Gonorrhea Q1: What test should be completed for accurately diagnosing gonorrhea? A1: Testing is done with either a culture or a NAAT (nucleic acid amplification test).
More informationSTANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT
STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT RELEASE DATE: REVIEW INTERVAL: YEARLY REVIEW DATE: SITE/SERVICE UNIT: IMPLEMENTATION DATE: REVIEWED BY: CONTACT: APPROVED BY: CONTENTS
More informationCDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.
CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships
More informationSTD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment
STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative Pregnancy Chlamydia Chancroid Epdidymitis Gonorrhea: Uncomplicated (cx, urethra, and rectum):
More informationZika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases
Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several
More informationSyphilis. Communicable Disease Management Protocol. 1. Etiology. 2. Case Definitions
Syphilis Public Health Branch 1. Etiology Syphilis is primarily a sexually transmitted bacterial infection (STI). Syphilis can also be acquired through congenital transmission to the newborn and through
More informationTHIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)
More informationGONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)
Key practice notes: 1 st line therapy GONORRHOEA Decreasing sensitivity of gonorrhoea to cephalosporins is now a real threat: CEFTRIAXONE 500mg IM stat first-line for all gonococcal infections AZITHROMYCIN
More informationExpedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon
Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Oregon Health Authority Center for Public Health Practice HIV/STD/TB Section Principles of
More informationCongenital Syphilis. RPA Newborn Care Guidelines Royal Prince Alfred Hospital. Introduction. Incidence and Risk Factors. Clinical Features 1, 2
RPA Newborn Care Guidelines Royal Prince Alfred Hospital Introduction Congenital Syphilis Syphilis is a notifiable disease. Maternal syphilis can be divided into primary, secondary, latent and tertiary
More informationWA Endemic Regions STI/HIV Control Supplement
WA Endemic Regions STI/HIV Control Supplement MAY 2013 Contents INTRODUCTION... 2 HEALTH UNITS CONTACTS... 3 RATES OF CHLAMYDIA, GONORRHOEA AND SYPHILIS NOTIFICATIONS IN THE GOLDFIELDS, KIMBERLEY, MIDWEST
More informationSexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised)
Sexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised) Preamble The Ontario Public Health Standards (OPHS) are published by the Minister of Health and Long- Term
More informationsigns suggesting chlamydia:
Chlamydia - uncomplicated genital - Management View full scenario When should I suspect and test for chlamydia? Women: o Test for chlamydia if they are sexually active with symptoms and signs suggesting
More information2010 STD Treatment Guidelines: Update for Primary Care Providers
2010 STD Treatment Guidelines: Update for Primary Care Providers Sharon Adler, MD MPH STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Overview CDC
More informationVARICELLA ZOSTER (VZ) VIRUS, CHICKENPOX & SHINGLES GUIDANCE
VARICELLA ZOSTER (VZ) VIRUS, CHICKENPOX & SHINGLES GUIDANCE Summary This guidance provides background information on varicella zoster (VZ), chickenpox and shingles and sets out the infection control measures
More informationAlberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2012
Alberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2012 General for STI Given the current rates of STI in Alberta, Some STI are under the Patients and contacts
More informationImmunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by
Immunization Healthcare Branch Human Papillomavirus Vaccination Program Questions and Answers Prepared by Immunization Healthcare Branch (IHB), Defense Health Agency Last Updated: 02 Jan 14 www.vaccines.mil
More informationTHE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE
THE UNITED REPUBLIC OF TANZANIA Treat for Lymphogranuloma venereum MINISTRY OF HEALTH AND SOCIAL WELFARE Appoint to return after Patient complains of Use Discharge from Continue to 2nd Refer to surgeon
More informationDiagnosis and Treatment Regimes for Syphilis By Dr John Bannister
Diagnosis and Treatment Regimes for Syphilis By Dr John Bannister Syphilis: Serological Testing Introduction In an ideal world a practitioner would have assessed a patient s medical history with regards
More informationYes, I know I have genital herpes:
Counseling Messages for Herpes Simplex Type II (HSV-II) Genital herpes Always take the time to attend to the participant s feelings and emotional state; for some people, this is the most devastating news
More informationTUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG
TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG Tx CENTERS Tuberculosis Control Program Health and Human Services Agency San Diego County INTRODUCTION Reducing TB disease requires
More informationThe Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information
More informationA guide for people with genital herpes
A guide for people with genital herpes Contents Getting the facts 4 The key facts 6 What is genital herpes? 8 Genital herpes symptoms 10 Getting tested 12 The first outbreak 14 Recurrent outbreaks 16 Common
More informationA P P E N D I X SAMPLE FORMS
A P P E N D I X A SAMPLE FORMS Authorization for Disclosure Consent for HBV/HCV Antigens, HIV Antibody Documentation of Staff Education Employees Eligible for Hepatitis-B Vaccination Hepatitis-A Consent
More informationOutpatient/Ambulatory Health Services
Outpatient/Ambulatory Health Services Service Definition Outpatient/ambulatory medical care includes the provision of professional diagnostic and therapeutic services rendered by a physician, physician
More informationGUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA
GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA 2010 1 TB prophylaxis GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS Background
More informationGARPR Online Reporting Tool
GARPR Online Reporting Tool 0 Narrative Report and Cover Sheet 1) Which institutions/entities were responsible for filling out the indicator forms? a) NAC or equivalent Yes b) NAP Yes c) Others Yes If
More informationThe challenge of herpes
The challenge of herpes Herpes is a common and personally challenging disease Herpes is very common. One out of four adults has genital herpes. When people first hear that they are infected, many become
More informationSYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization
WHO COLLABORATING CENTRE FOR RESEARCH IN HUMAN REPRODUCTION Hôpitaux Universitaires de Genève SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization Dr SALONEY NAZEER Department of Gynaecology
More informationIn Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs.
ANTIRETROVIRAL TREATMENT What is ART and ARV? ART is a short form for Antiretroviral Therapy (or Treatment). Antiretroviral therapy is a treatment consisting of a combination of drugs which work against
More informationAIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS
AIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS An Air Force addendum to the TRI-SERVICE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS Prepared by: Air Force Institute for Operational Health
More informationAssisted Living - TB Risk Assessment
Montana DPHHS Tuberculosis Program Assisted Living - TB Risk Assessment Assisted Living, Adult Day Care, Adult Foster Care & Transitional Living Centers Today s Date Facility Address Phone County Completed
More informationSTI case management. Francis Ndowa - GFMER Theodora Wi - WHO
Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care STI case management Francis Ndowa - GFMER Theodora
More informationTitle: Antibiotic Guideline for Acute Pelvic Inflammatory Disease
Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Version 3 Date ratified December 2007 Review date December 2009 Ratified by NUH Antimicrobial Guidelines Committee Gynaecology Directorate
More informationAccent on Health Obgyn, PC HERPES Frequently Asked Questions
1. What is herpes? 2. How common is herpes? 3. Is there a cure for herpes? 4. What is oral herpes (cold sores)? 5. How is oral herpes spread? 6. What is genital herpes? 7. How is genital herpes spread?
More informationAntibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Contents
Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine
More informationINTRODUCTION: CPT CODES & ICD-9 CODES
INTRODUCTION: CPT CODES & ICD-9 CODES Current Procedural Terminology (CPT) is a listing of descriptive terms and identifying codes for reporting medical services and procedures performed by physicians.
More informationUrinary Tract Infections
Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of
More informationWilliam Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016
William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15
More informationHIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer
HIV/AIDS Care: The Diagnosis Code Series 2 Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer Learning Outcomes Identify and explain the difference between ICD-9-CM
More informationDisclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
Mitzi Joi Williams, MD Neurologist MS Center of Atlanta, Atlanta, GA Disclosures Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics
More informationUK National Guidelines on the Management of Syphilis 2008
GUIDELINES UK National Guidelines on the Management of Syphilis 2008 M Kingston BMBS MRCP*, P French MBChB FRCP, B Goh FRCP, P Goold MBBS MRCP, S Higgins FRCP**, A Sukthankar FRCP*, C Stott RGN BSc*, A
More informationMANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol)
MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol) 1. Hepatotoxicity: In Active TB Disease a. Background: 1. Among the 4 standard anti-tb drugs,
More informationFREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH)
FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH) What is pertussis? General Questions About Pertussis Pertussis, or whooping cough, is a contagious illness that is spread when an infected person
More informationARIZONA SEXUALLY TRANSMITTED DISEASE OUTBREAK RESPONSE PLAN
PREFACE ARIZONA SEXUALLY TRANSMITTED DISEASE OUTBREAK RESPONSE PLAN Arizona Department of Health Services Division of Public Health Services Office of HIV, STD, and Hepatitis C Services Sexually Transmitted
More informationPertussis Information for GPs and other Health Care Providers on Clinical and Public Health Management. March 2010
Pertussis Information for GPs and other Health Care Providers on Clinical and Public Health Management March 2010 Infectious Agent Bordetella pertussis (a bacterium) Clinical Features Infants and Young
More informationChlamydia THE FACTS. How do people get Chlamydia?
What is Chlamydia? Chlamydia is a common bacterial infection that is sexually transmitted and often causes no symptoms. If not treated, chlamydia can damage reproductive organs and make it difficult for
More informationALBERTA IMMUNIZATION POLICY GUIDELINES
ALBERTA IMMUNIZATION POLICY GUIDELINES Hepatitis Vaccines. Hepatitis A Vaccines Refer to the vaccine product monograph and the Canadian Immunization Guide for further Product monographs are available on
More informationSOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant
SOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant Foreword The rapid emergence of Zika virus as a potential causative agent for fetal
More informationFLU VACCINATION - FREQUENTLY ASKED QUESTIONS
FLU VACCINATION - FREQUENTLY ASKED QUESTIONS SEASONAL FLU VACCINATION 2015 2016 As a health care worker, am I required to be vaccinated against influenza (the flu)? It is not mandatory to be vaccinated
More informationMUMPS PUBLIC FREQUENTLY ASKED QUESTIONS
New Jersey Department of Health Vaccine Preventable Disease Program MUMPS PUBLIC FREQUENTLY ASKED QUESTIONS Date: April 17, 2014 DESCRIPTION OF MUMPS What is mumps? Mumps is a disease that is caused by
More informationFrequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013
Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013 On July 16, 2012, the Food and Drug Administration (FDA) approved
More informationNurse Initiated STI Treatment Code
Nurse Initiated STI Treatment Code Public Health and Clinical Services Division June 2012 FORWARD The Nurse Initiated STI Treatment Code establishes the competencies which must be achieved and criteria
More informationChanges in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011
Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011 Gale Burstein, MD, MPH, FAAP, FSAHM 1 Amanda Jacobs, MD, FAAP, 2 Dmitry Kissin, MD, MPH, 3
More informationOther Causes of Fever
T e c h n i c a l S e m i n a r s Other Causes of Fever Febrile Illness Causes Fever After Seven Days Referral Relapsing Fever - Borreliosis Overview JHR Adaptation Sore Throat Overview Prevention Management
More informationGeneral Colorado Immunization Guidelines... 3. Varicella (Chickenpox) Disease and Varicella Vaccine... 4. DTaP/Tdap/Td Vaccines...
General Colorado Immunization Guidelines... 3 What is the difference between Colorado school required immunizations and immunizations that are recommended?... 3 What is the 4 day grace period for vaccines
More informationMANAGEMENT OF TUBERCULOSIS
MANAGEMENT OF TUBERCULOSIS Dean B. Ellithorpe, M.D. Clinical Professor of Medicine Section of Pulmonary Diseases, Critical Care and Environmental Medicine Tulane University School of Medicine INTRODUCTION
More informationImmunization Frequently Asked Questions for K-12 th Grades 2015-2016 Colorado School Required Immunizations
Immunization Frequently Asked Questions for K-12 th Grades 2015-2016 Colorado School Required Immunizations General Colorado Immunization Guidelines... 3 What does is mean for a school to be in compliance
More informationNurse Aide Training Program Application Checklist
Nurse Aide Training Program Application Checklist The following checklist must be completed before enrolling in the Nurse Aide Training course: Complete, sign, and date the Application Form Have the physical
More informationPOST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING
MARCH 2014 A Quick Guide to POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING HIV PROVIDER REFERENCE SERIES A PUBLICATION OF THE MOUNTAIN PLAINS AIDS EDUCATION AND TRAINING CENTER MountainPlains AIDS
More informationINITIATING ORAL AUBAGIO (teriflunomide) THERAPY
FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been
More informationCOMMUNICABLE DISEASE
Public Health Activities & Services Inventory Technical Notes COMMUNICABLE DISEASE CLINICAL SERVICES, SURVEILLANCE AND CONTROL In 2014, decision was made to adopt number of national public health activities
More informationThioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid
Package Leaflet: Information for the User Thioctacid 600 T Solution for Injection contains 600 mg alpha-lipoic acid For use in adults Active substance: Alpha-lipoic acid, Trometamol salt (1:1) Read all
More informationNHS FORTH VALLEY Guidelines for Hepatitis B Vaccination in High Risk Groups
NHS FORTH VALLEY Guidelines for Hepatitis B Vaccination in High Risk Groups Approved 01/04/2012 Version 1.0 Date of First Issue 01/04/2012 Review Date 01/02/2014 Date of Issue 01/04/2012 EQIA Yes Author
More informationClinical Performance Director of Nursing Allison Bussey
PGD 0314 Patient Group Direction Administration of Adrenaline (Epinephrine) 1:1000 (1mg/ml) Injection By Registered Nurses employed by South Staffordshire & Shropshire Healthcare Foundation NHS Trust This
More informationPrevention and Recognition of Obstetric Fistula Training Package. Module 8: Pre-repair Care and Referral for Women with Obstetric Fistula
Prevention and Recognition of Obstetric Fistula Training Package Module 8: Pre-repair Care and Referral for Women with Obstetric Fistula Early detection and treatment If a woman has recently survived a
More informationSMO: Anaphylaxis and Allergic Reactions
REGION I EMERGENCY MEDICAL SERVICES STANDING MEDICAL ORDERS EMT Basic SMO: Anaphylaxis and Allergic Reactions Overview: Allergic reactions can vary in severity from a mild reaction consisting of hives
More informationSECTION SEVEN INSTITUTIONAL POLICIES RELATIVE TO GME PROGRAMS POLICY NO: 7. 6 SUBJECT: EMPLOYEE HEALTH SERVICE PROCEDURES AND GUIDELINES
SECTION SEVEN INSTITUTIONAL POLICIES RELATIVE TO GME PROGRAMS POLICY NO: 7. 6 SUBJECT: EMPLOYEE HEALTH SERVICE PROCEDURES AND GUIDELINES l. PURPOSE To provide management guidelines for Infection Control
More informationMedia Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com
News Release FOR IMMEDIATE RELEASE Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com Merck's HPV Vaccine, GARDASIL 9, now available
More informationFAQs on Influenza A (H1N1-2009) Vaccine
FAQs on Influenza A (H1N1-2009) Vaccine 1) What is Influenza A (H1N1-2009) (swine flu) 1? Influenza A (H1N1-2009), previously known as "swine flu", is a new strain of influenza virus that spreads from
More informationMINISTRY OF HEALTH PANDEMIC INFLUENZA A / H1N1 2009 VACCINE FREQUENTLY ASKED QUESTIONS
Government of the Republic of Trinidad and Tobago MINISTRY OF HEALTH PANDEMIC INFLUENZA A / H1N1 2009 VACCINE FREQUENTLY ASKED QUESTIONS Influenza vaccines are one of the most effective ways to protect
More informationResource Document 6: Tetanus Immunization. I. Introduction
Resource Document 6: Tetanus Immunization I. Introduction Attention must be directed to adequate tetanus prophylaxis in the multiply injured patient, particularly if open-extremity trauma is present. The
More informationSyphilis is a sexually transmitted disease (STD)
R e v i e w o f C l i n i c a l S i g n s Manifestations of Syphilis Bernard M. Karnath, MD Series Editor: Bernard M. Karnath, MD Syphilis is a sexually transmitted disease (STD) caused by the Treponema
More informationMEDICATION GUIDE. PROCRIT (PRO KRIT) (epoetin alfa)
MEDICATION GUIDE PROCRIT (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. if you are
More informationTopical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement
Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement A Copy of this page signed by all three parties should be retained in the
More informationBASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC
BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC HIV What are HIV and AIDS? HIV stands for Human Immunodeficiency Virus. This is the virus that causes AIDS. HIV is
More informationQUICK REFERENCE TO BLOOD BANK TESTING
QUICK REFERENCE TO BLOOD BANK TESTING All Blood bank Tests are performed on demand 24 hours a day, 7 days a week. Feto/Maternal Bleed Quantitation estimates will be available within 4 hours of blood bank
More informationRecommendations for Emergency Departments in Caring for Potential Ebola Virus Disease (EVD) Patients
Recommendations for Emergency Departments in Caring for Potential Ebola Virus Disease (EVD) Patients Provincial Ebola Expert Working Group March 10, 2015 Contents A. Preamble... 3 B. Guiding Principles...
More informationALTERNATIVE TREATMENT PLAN AND CONSENT FOR MEDICAL ABORTION WITH MIFEPREX (MIFEPRISTONE) AND MISOPROSTOL
ALTERNATIVE TREATMENT PLAN AND CONSENT FOR MEDICAL ABORTION WITH MIFEPREX (MIFEPRISTONE) AND MISOPROSTOL The FDA gave its approval status to Mifepristone in 1996 based on research up to that time. Extensive
More informationTest Request Tip Sheet
With/Without Contrast CT, MRI Studies should NOT be ordered simultaneously as dual studies (i.e., with and without contrast). Radiation exposure is doubled and both views are rarely necessary. The study
More informationPediatric Latent TB Diagnosis and Treatment
Date Updated: April 2015 Guidelines Reviewed: 1. CDC Latent TB Guidelines 2. Harborview Pediatric Clinic Latent TB Management, 2010 3. Pediatric Associates Latent TB Guidelines, 2013 4. Seattle Children
More informationSummary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014
Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014 1 Background l Selected types of HPV cause cervical cancer, anogenital warts, and other anogenital and
More informationBody Fluid Exposure:
Focus on CME at the University of Manitoba Focus on CME at the University of Manitoba Body Fluid Exposure: What To Do? John Sokal, MD, CFPC Presented at Bug Day 2003, Health Sciences Centre, Winnipeg (October
More informationLong-term Care - TB Risk Assessment
Montana DPHHS Tuberculosis Program Long-term Care - TB Risk Assessment Long-term Care, Residential Treatment, ESRD (outpatient), Hospice (inpatient) Today s Date Facility Address Phone County Completed
More information2. Characteristics of staff Qualifications required. Additional requirements. Continued education & training requirements
Patient Group Direction The supply of Azithromycin 1g as a single dose by accredited Community Pharmacists to patients in receipt of a positive test result to Chlamydia trachomatis, and treatment of their
More informationFrequently Asked Questions (FAQs)
Frequently Asked Questions (FAQs) Research Rationale 1. What does PrEP stand for? There is scientific evidence that antiretroviral (anti-hiv) medications may be able to play an important role in reducing
More informationAntimicrobial Resistance & Infections. Clinical Perspectives
Antimicrobial Resistance & Sexually Transmitted Infections Clinical Perspectives Outline Neisseria gonorrhoeae Global threat of untreatable gonorrhoea Mycoplasma genitalium Rapid loss of treatment options
More informationImmunization Information for Blinn College Students
1 Immunization Information for Blinn College Students *Important Information Regarding the Bacterial Meningitis Vaccine* The State passed Senate Bill 1107 in 2011 and recently Senate Bill 62 in 2013, which
More informationOUTLINE POST EXPOSURE PROPHYLAXIS (PEP) OCCUPATIONAL RISK OF VIRAL TRANSMISSION WITH SHARP INJURY FROM INFECTED SOURCE:
Professional needle stick accidents should be dealt with within 48 hours. An ARC (Aids Reference Centre) or an emergency department must be contacted as soon as possible. OUTLINE POST EXPOSURE PROPHYLAXIS
More informationAllergies: ENT and Allergy Center of Missouri YOUR GUIDE TO TESTING AND TREATMENT. University of Missouri Health Care
Allergies: YOUR GUIDE TO TESTING AND TREATMENT ENT and Allergy Center of Missouri University of Missouri Health Care 812 N. Keene St., Columbia, MO 65201 (573) 817-3000 www.muhealth.org WHAT CAUSES ALLERGIES
More informationEastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families
Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you
More information